| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge [B. L., I. P-H., J-Å. G., A. B.], and Department of Toxicological Genetics, University of Stockholm, S-106 91 Stockholm [I. P-H.], Sweden
Marked sex differences in the growth of enzyme-altered hepatic foci have been observed in rats treated according to the "resistant hepatocyte model." The present study was performed to investigate the effect of neonatal and adult castration of male rats, with or without testosterone substitution, on the growth rate of foci during selection of initiated cells with 2-acetylaminofluorene and partial hepatectomy. Neonatal castration of male rats decreased focal growth to the same level as in female rats. Castration of adult male rats 2 wk before initiation with diethylnitrosamine also decreased the growth rate of foci, but less markedly than in neonatally castrated rats. Testosterone substitution of male rats castrated as neonates or as adults, from 10 days after initiation with diethylnitrosamine, restored focal growth to that of sham-castrated controls. Previous investigations concerning the role of gonadal hormones in sex differentiation of various liver functions indicated a role of the hypothalamopituitary-liver axis in mediating the effects of androgens. It is therefore also suggested that the effects of androgens on early steps of hepatocarcinogenesis observed in the present study are mediated by similar mechanisms, possibly through an influence on the metabolism of 2-acetylaminofluorene.
1 This study was supported by grants from the NIH (IRO1 CA42, 054-01A1), the Torsten and Ragnar Söderberg Foundation, the Swedish Cancer Society, and the Cancer Society in Stockholm.
2 To whom requests for reprints should be addressed, at Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, F 60 Novum, S-141 86 Huddinge, Sweden.
Received 8/21/89.
Revised 1/10/90.
This article has been cited by other articles:
![]() |
J. M. Bugni, T. M. Poole, and N. R. Drinkwater The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maruyama, N. Nagasue, D. K. Dhar, A. Yamanoi, O. N. El-Assal, K. Satoh, and K. Okita Preventive Effect of FK143, a 5{{alpha}}-Reductase Inhibitor, on Chemical Hepatocarcinogenesis in Rats Clin. Cancer Res., July 1, 2001; 7(7): 2096 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, H. Sakai, M. Hashizume, and T. Hirohata Serum Testosterone:Estradiol Ratio and the Development of Hepatocellular Carcinoma among Male Cirrhotic Patients Cancer Res., September 1, 2000; 60(18): 5106 - 5110. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |